ArticleThe oncologist2025

Clinical impact of TP53 functional mutations in patients with metastatic colorectal cancer treated with bevacizumab and chemotherapy.

Annamaria Ruzzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.